So, lets take your more conservative approach of $12.91 and assume the GM maintains at 59%. This will deliver a gross margin of $7.6M, which is higher than last years expenses (taking out non cash items, such as depreciation). I would expect operational cashflow to be positive, depending on how much stock/inventory is accumulated going into FY25. But a significant milestone appears to be on the horizon.
Ann: Revenue Update, page-9
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.060(11.5%) |
Mkt cap ! $124.7M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 58.5¢ | 53.0¢ | $1.045M | 1.858M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2260 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 4539 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BIO (ASX) Chart |